| Breakdown | Dec 2025 | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 30.66M | 30.24M | 15.63M | 144.00K |
| Gross Profit | -10.49M | -1.06M | -18.12M | -19.05M | -8.91M |
| EBITDA | -20.92M | -16.45M | -891.00K | -53.10M | 49.23M |
| Net Income | -12.41M | -75.39M | -19.33M | -65.40M | 1.47M |
Balance Sheet | |||||
| Total Assets | 736.04M | 739.02M | 745.93M | 747.72M | 755.72M |
| Cash, Cash Equivalents and Short-Term Investments | 1.06M | 841.00K | 1.02M | 542.00K | 312.00K |
| Total Debt | 353.02M | 383.21M | 351.05M | 352.77M | 307.91M |
| Total Liabilities | 707.91M | 722.17M | 654.88M | 637.71M | 579.36M |
| Stockholders Equity | 30.04M | 18.44M | 92.27M | 111.01M | 177.05M |
Cash Flow | |||||
| Free Cash Flow | -5.83M | -4.30M | -10.37M | -22.92M | -12.71M |
| Operating Cash Flow | -5.83M | -2.97M | -7.59M | -21.32M | -9.89M |
| Investing Cash Flow | -119.03K | -735.00K | -2.77M | -1.59M | -2.81M |
| Financing Cash Flow | 6.68M | 3.52M | 10.37M | 23.13M | 12.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$12.99B | 7.48 | 9.87% | 20.93% | 9.52% | -28.22% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
50 Neutral | HK$260.73M | 9.64 | 6.66% | ― | -61.60% | ― | |
49 Neutral | HK$803.20M | 10.11 | 4.05% | ― | -14.14% | -59.17% | |
42 Neutral | HK$445.54M | -0.53 | -82.00% | ― | -40.63% | -1501.63% | |
41 Neutral | HK$205.69M | -2.63 | -113.92% | ― | -100.00% | 88.01% | |
40 Underperform | HK$226.02M | -1.19 | 37.85% | ― | 34.46% | -1.42% |